Health Outcomes in Rheumatoid Arthritis
This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.
Status: Recruiting (N/A).
Enrollment: 260 subjects
Study Type: Observational
Study Design:
- Psychosocial
- Longitudinal
- Defined Population
- Prospective Study
Conditions:
Interventions:
Eligibility
Inclusion Criteria:
Males and females age 19 or older
Current active, adult-onset rheumatoid arthritis who meet ACR criteria for RA and have: (American College of Rheumatology [ACR] functional class I–III), defined as:
3 or more swollen or tender joints and
Morning stiffness of 45min or longer
OR judged by their rheumatologist to have active disease
No evidence of other inflammatory diseases (e.g., Crohn’s, IBS)
Functional class I, II or III
Exclusion Criteria:
Individuals with significant cardiovascular disease (CHF, stroke, MI)
Unwilling to have medications monitored and/or comply with protocol
Not fluent in English
Planning to move from area within next year or change health insurance (which would preclude ongoing care by JH rheumatologist)
Enrolled in study evaluating efficacy of new or existing RA medications
- Gender
Both
- Mininum Age
19 Years
- Maximum Age
N/A
- Healthy Volunteers
No
Resources
Source: Johns Hopkins University
Authority: United States: Institutional Review Board
Locations
-
Johns Hopkins Bayview Campus
Baltimore
Maryland
21224
United States
-
Good Samaritan Hospital
Baltimore
Maryland
21239
United States
Officials
Susan Bartlett, PhD (Principal Investigator, Johns Hopkins School of Medicine)
Steffany Haaz, MFA (Study Director, Johns Hopkins University)
Sponsors
Johns Hopkins University (Lead Sponsor)
References
None.
Links
None.
- Date Verified
- May 1st, 2006
- First Received
- June 28th, 2006
- Last Changed
- June 28th, 2006
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.